Study of Efficacy and Safety of Omalizumab in Severe Japanese Cedar Pollinosis Adult and Adolescent Patients

NCT03369704 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

337

Enrollment

INDUSTRY

Sponsor class

Conditions

Seasonal Allergic Rhinitis

Interventions

DRUG: Omalizumab
DRUG: Placebo

Sponsor

Novartis Pharmaceuticals